Agenda

10 minutes  Overview
20 minutes  Case 1: Treatment-naïve Patients
20 minutes  Case 2: Care of Women: Treatment-naïve Women with Reproductive Needs
10 minutes  Question and Answer Session

Goals (Purpose) of Program

The purpose of this educational activity is to provide healthcare professionals with new insights into the optimal management with antiretrovirals of treatment-naïve patients with HIV.

Learning Objectives

At the conclusion of this activity, participants should be better able to:

• Summarize the new updates and developments in the latest evidence-based guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents
• Initiate a guideline-recommended antiretroviral regimen in treatment-naïve patients to achieve maximal viral suppression
• Implement an effective use of antiretroviral agents in pregnant HIV-1-infected women to improve maternal health and reduce perinatal mother-to-child transmission of HIV
• Provide appropriate care and counsel for treatment-naïve patients with HIV-1 infection and their families as part of the treatment plan

Target Audience

This activity is designed for physicians, registered nurses, pharmacists, and other healthcare professionals interested in optimally managing patients with HIV.

AudioWeb Schedule

Monday, May 16, 2011 - 1:00 PM EDT
Tuesday, May 17, 2011 - 12:00 PM EDT
Wednesday, May 18, 2011 - 3:30 PM EDT
Thursday, May 19, 2011 - 1:00 PM EDT
Friday, May 20, 2011 - 12:00 PM EDT
Monday, May 23, 2011 - 1:00 PM EDT
Tuesday, May 24, 2011 - 8:00 PM EDT
Wednesday, May 25, 2011 - 12:00 PM EDT
Thursday, May 26, 2011 - 12:00 PM EDT
Thursday, June 2, 2011 - 1:30 PM EDT
Tuesday, June 7, 2011 - 1:00 PM EDT

For questions call (877) 374-8323 or email hivcare4@accelmed.org

Activity Description

In this activity, a faculty of experienced clinicians will discuss cases that incorporate newly emerged scientific research data and clinical treatment strategies. The faculty will summarize the new updates and developments in the latest evidence-based guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Particularly, the faculty will discuss how to initiate and prescribe a guideline-recommended antiretroviral regimen in treatment-naïve patients. Moreover, the faculty will illustrate an effective use of antiretroviral agents in pregnant HIV-1-infected women to improve maternal health and reduce perinatal mother-to-child transmission of HIV. The activity will conclude with an interactive question and answer session.

Statement of Educational Need

The human immunodeficiency virus (HIV) results in relentless destruction of the immune system, eventually leading to acquired immunodeficiency syndrome (AIDS), especially without the intervention of highly active antiretroviral therapy (HAART). There are an estimated 56,000 new infections in the United States and a staggering 2.7 million new infections occurring in the world every year. Since the "golden age" of HIV treatment began in the late 90s with the introduction of a triple combination cocktail therapy regimen, more than 20 HIV medications have been approved, which has resulted in a dramatic improvement of clinical outcomes in patients with HIV infection. However, many lingering issues still exist such as high cross-class resistance, pill burden, dosing schedule, safety and tolerability profiles, drug-drug interactions, and comorbid conditions including cardiovascular disease, diabetes, and coinfections with hepatitis B and C. Furthermore, the AIDS epidemic has had a unique impact on women, which has been exacerbated by their biological vulnerability to HIV infection. Particularly, women with fertility desires pose unique challenges in HIV care. As a result, various evidence-based guidelines for the use of antiretroviral agents to control HIV replication are frequently updated to keep in pace with the rapid emergence of data in this field. Clinicians who manage patients with HIV infection should keep abreast of the latest developments to provide the best possible care to their patients.

Media

Live AudioWeb

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician
Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ACCELMED. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse
Accreditation Statement

The Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

This educational activity for 1.2 contact hours is provided by the Postgraduate Institute for Medicine.

California Board of Registered Nursing

The Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.2 contact hours.

Pharmacist
Accreditation Statement

The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

The Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number 0809-9999-11-068-L02-P). ACPE live release date: 05/16/2011.

Statement of Commercial Support

This activity is supported by an educational grant from Merck & Co., Inc.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s condition and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine (PIM), ACCELMED, and Merck & Co., Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ACCELMED, and Merck & Co., Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Contact Information for Questions about the Activity

If you have any questions relating to technical issues for this activity, please contact ACCELMED:
Phone: (866) 232-2363
Email: hivcare4@accelmed.org

Hardware / Software Requirements

• Flash Player 6.0.79 or later (http://www.adobe.com/go/getflash) (Flash Player 7 or later recommended), and one of the following browsers:
• Windows: Internet Explorer 6, Internet Explorer 7, Firefox 1.x and later, Safari 3, Google Chrome, Opera 9.5
• Macintosh: Firefox 1.x and later, Safari 3
• Linux: Firefox 1.x

Instructions for Receiving Credit

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.

Type of Activity

Knowledge

Jointly sponsored/Co-provided by the Postgraduate Institute for Medicine and ACCELMED.